Click for best price
Postpemic Era Vaccines & Vaccination Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Vaccines & Vaccination Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Vaccines & Vaccination industry at home and abroad, estimate the overall market scale of the Vaccines & Vaccination industry and the market share of major countries, Vaccines & Vaccination industry, and study and judge the downstream market demand of Vaccines & Vaccination through systematic research, Analyze the competition pattern of Vaccines & Vaccination, so as to help solve the pain points of various stakeholders in Vaccines & Vaccination industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Vaccines & Vaccination Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Vaccines & Vaccination Market?
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Major Type of Vaccines & Vaccination Covered in XYZResearch report:
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Application Segments Covered in XYZResearch Market
Baby Vaccine
Adult Special Vaccine
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Vaccines & Vaccination Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
99 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Vaccines & Vaccination Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Vaccines & Vaccination Market by Value
2.2.1 Global Vaccines & Vaccination Revenue by Type
2.2.2 Global Vaccines & Vaccination Market by Value
2.3 Global Vaccines & Vaccination Market by Sales
2.3.1 Global Vaccines & Vaccination Sales by Type
2.3.2 Global Vaccines & Vaccination Market by Sales
3. The Major Driver of Vaccines & Vaccination Industry
3.1 Historical & Forecast Global Vaccines & Vaccination Sales and Revenue (2018-2028)
3.2 Largest Application for Vaccines & Vaccination (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Vaccines & Vaccination Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Vaccines & Vaccination Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Vaccines & Vaccination Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Vaccines & Vaccination Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Vaccines & Vaccination Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Vaccines & Vaccination Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Vaccines & Vaccination Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Vaccines & Vaccination Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Vaccines & Vaccination Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Vaccines & Vaccination Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Vaccines & Vaccination Average Price Trend
13.1 Market Price for Each Type of Vaccines & Vaccination in US (2018-2022)
13.2 Market Price for Each Type of Vaccines & Vaccination in Europe (2018-2022)
13.3 Market Price for Each Type of Vaccines & Vaccination in China (2018-2022)
13.4 Market Price for Each Type of Vaccines & Vaccination in Japan (2018-2022)
13.5 Market Price for Each Type of Vaccines & Vaccination in India (2018-2022)
13.6 Market Price for Each Type of Vaccines & Vaccination in Korea (2018-2022)
13.7 Market Price for Each Type of Vaccines & Vaccination in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Vaccines & Vaccination in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Vaccines & Vaccination Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Vaccines & Vaccination
15. Vaccines & Vaccination Competitive Landscape
15.1 Abbott
15.1.1 Abbott Company Profiles
15.1.2 Abbott Product Introduction
15.1.3 Abbott Vaccines & Vaccination Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 AstraZeneca
15.2.1 AstraZeneca Company Profiles
15.2.2 AstraZeneca Product Introduction
15.2.3 AstraZeneca Vaccines & Vaccination Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Bavarian Nordic
15.3.1 Bavarian Nordic Company Profiles
15.3.2 Bavarian Nordic Product Introduction
15.3.3 Bavarian Nordic Vaccines & Vaccination Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Novartis
15.4.1 Novartis Company Profiles
15.4.2 Novartis Product Introduction
15.4.3 Novartis Vaccines & Vaccination Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Bharat Biotech
15.5.1 Bharat Biotech Company Profiles
15.5.2 Bharat Biotech Product Introduction
15.5.3 Bharat Biotech Vaccines & Vaccination Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Bio-Med
15.6.1 Bio-Med Company Profiles
15.6.2 Bio-Med Product Introduction
15.6.3 Bio-Med Vaccines & Vaccination Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 CSL
15.7.1 CSL Company Profiles
15.7.2 CSL Product Introduction
15.7.3 CSL Vaccines & Vaccination Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Emergent BioSolutions
15.8.1 Emergent BioSolutions Company Profiles
15.8.2 Emergent BioSolutions Product Introduction
15.8.3 Emergent BioSolutions Vaccines & Vaccination Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 GSK
15.9.1 GSK Company Profiles
15.9.2 GSK Product Introduction
15.9.3 GSK Vaccines & Vaccination Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Johnson & Johnson
15.10.1 Johnson & Johnson Company Profiles
15.10.2 Johnson & Johnson Product Introduction
15.10.3 Johnson & Johnson Vaccines & Vaccination Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Pfizer
15.12 Merck
15.13 Sanofi
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Vaccines & Vaccination Industry (Volume)
Figure 2. Vaccines & Vaccination Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2022
Figure 5. US Vaccines & Vaccination Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Vaccines & Vaccination Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Vaccines & Vaccination Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Vaccines & Vaccination Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Vaccines & Vaccination Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Vaccines & Vaccination Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Vaccines & Vaccination Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Vaccines & Vaccination Revenue, by Type (Million USD) (2018-2028)
Table 4. Vaccines & Vaccination Sales, by Type (K Unit) (2018-2028)
Table 5. Vaccines & Vaccination Sales (K Unit) by Application (2018-2028)
Table 6. Vaccines & Vaccination Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Vaccines & Vaccination Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Vaccines & Vaccination Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Vaccines & Vaccination in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott Vaccines & Vaccination Product Introduction
Table 62. Abbott Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. AstraZeneca Profiles
Table 65. AstraZeneca Vaccines & Vaccination Product Introduction
Table 66. AstraZeneca Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. AstraZeneca Strategic initiatives
Table 68. Bavarian Nordic Profiles
Table 69. Bavarian Nordic Vaccines & Vaccination Product Introduction
Table 70. Bavarian Nordic Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bavarian Nordic Strategic initiatives
Table 72. Novartis Profiles
Table 73. Novartis Vaccines & Vaccination Product Introduction
Table 74. Novartis Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Novartis Strategic initiatives
Table 76. Bharat Biotech Profiles
Table 77. Bharat Biotech Vaccines & Vaccination Product Introduction
Table 78. Bharat Biotech Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Bharat Biotech Strategic initiatives
Table 80. Bio-Med Profiles
Table 81. Bio-Med Vaccines & Vaccination Product Introduction
Table 82. Bio-Med Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Bio-Med Strategic initiatives
Table 84. CSL Profiles
Table 85. CSL Vaccines & Vaccination Product Introduction
Table 86. CSL Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. CSL Strategic initiatives
Table 88. Emergent BioSolutions Profiles
Table 89. Emergent BioSolutions Vaccines & Vaccination Product Introduction
Table 90. Emergent BioSolutions Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Emergent BioSolutions Strategic initiatives
Table 92. GSK Profiles
Table 93. GSK Vaccines & Vaccination Product Introduction
Table 94. GSK Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. GSK Strategic initiatives
Table 97. Johnson & Johnson Profiles
Table 98. Johnson & Johnson Vaccines & Vaccination Product Introduction
Table 99. Johnson & Johnson Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Johnson & Johnson Strategic initiatives
Table 101. Pfizer Profiles
Table 102. Pfizer Vaccines & Vaccination Product Introduction
Table 103. Pfizer Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Pfizer Strategic initiatives
Table 105. Merck Profiles
Table 106. Merck Vaccines & Vaccination Product Introduction
Table 107. Merck Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Merck Strategic initiatives
Table 109. Sanofi Profiles
Table 110. Sanofi Vaccines & Vaccination Product Introduction
Table 111. Sanofi Vaccines & Vaccination Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Sanofi Strategic initiatives
